Related Experiment Video
Updated: Oct 15, 2026

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
Published on: September 21, 2021
Altered spermidine/spermine N1-acetyltransferase activity as a mechanism of cellular resistance to
1Department of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, USA. dem15@psu.edu
Abstract:
To develop a model system to investigate mechanisms of antiproliferative action of bis(ethyl)polyamine analogues, intermittent analogue treatments followed by recovery periods in drug-free medium were used to select an N(1), N(12)-bis(ethyl)spermine-resistant derivative of the Chinese hamster ovary cell line C55.7. The resulting C55.7Res line was at least 10-fold resistant to N(1),N(12)-bis(ethyl)spermine and N(1), N(11)-bis(ethyl)norspermine. The stability of the resistance in the absence of selection pressure was >/=9 months, indicating that a heritable genotypic change was responsible for the resistance phenotype. Polyamine transport alterations and multi-drug resistance were eliminated as causes of the resistance. Spermidine/spermine N(1)-acetyltransferase (SSAT) activity and regulation were altered in C55.7Res cells as basal activity was decreased, and no activity induction resulted from exposure to analogue concentrations, which caused 300-fold enzyme induction in parental cells. SSAT mRNA levels in the absence and presence of analogue were unchanged, but no SSAT protein was detected in C55.7Res cells. A point mutation, which results in the change leucine156 (a fully conserved residue) to phenylalanine, was identified in the C55.7Res SSAT cDNA. Expression of wtSSAT activity in C55.7Res cells restored sensitivity to bis(ethyl)polyamines. These results provided definitive evidence that SSAT activity is a critical target of the cytotoxic action of these analogues.
Insights
Researchers developed a drug-resistant cell line to study anticancer drugs. They found a mutation in the spermidine/spermine N(1)-acetyltransferase (SSAT) enzyme, proving it
Area of Science:
- Cell biology
- Molecular pharmacology
- Cancer research
Background:
- Bis(ethyl)polyamine analogues exhibit antiproliferative effects.
- Understanding resistance mechanisms is crucial for drug development.
Purpose of the Study:
- To develop a model system for investigating resistance to bis(ethyl)polyamine analogues.
- To elucidate the role of spermidine/spermine N(1)-acetyltransferase (SSAT) in analogue resistance.
Main Methods:
- Selection of a resistant Chinese hamster ovary cell line (C55.7Res) to N(1), N(12)-bis(ethyl)spermine.
- Analysis of polyamine transport, SSAT activity, mRNA, and protein levels.
- Sequencing of SSAT cDNA to identify mutations.
- Complementation studies by expressing wild-type SSAT in resistant cells.
Main Results:
- C55.7Res cells showed stable, heritable resistance to bis(ethyl)polyamines, independent of transport or multi-drug resistance.
- Basal SSAT activity was decreased in C55.7Res cells, with no induction upon analogue exposure.
- No SSAT protein was detected in resistant cells, despite unchanged mRNA levels.
- A point mutation (L156F) in SSAT cDNA was identified in C55.7Res cells.
- Restoration of wild-type SSAT activity re-sensitized cells to the analogues.
Conclusions:
- SSAT enzyme activity is a critical target for the antiproliferative action of bis(ethyl)polyamine analogues.
- A mutation in SSAT can confer resistance to these compounds.
- The C55.7Res cell line is a valuable tool for studying SSAT-mediated drug resistance mechanisms.
Related Concept Videos
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Abnormal Proliferation
Biosynthesis of Nucleic Acids
Antifungal Agents
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
